University Distinguished and MSU Foundation Professor
Michigan State University
Terrie E. Taylor, D.O. has been a life-long resident of Traverse City, Michigan. She attended Swarthmore College and the Chicago College of Osteopathic Medicine, and then interned at Riverside Osteopathic Hospital in Trenton, Michigan. Her first global health experience was in 1982, in the context of an NIH-funded research project in the Sudan – her interest in parasitic diseases, her delight in the challenges of working in resource-limited settings and her willingness to share all of this with medical students culminated in a faculty position at the Michigan State University College of Medicine in 1986 (following an internal medicine residency at Detroit Osteopathic Hospital and a Masters level course at the Liverpool School of Tropical Medicine).
She has been living and working in Malawi for six straight months each year (January – June, the “malaria season”) since 1986. Her focus has been on the pathogenesis of cerebral malaria. The research team clinical care for children with cerebral malaria and, in that context, study the disease. This has included conducting 4 interventional clinical trials, recognizing malarial retinopathy and establishing its importance, orchestrating the largest single autopsy study of fatal cerebral malaria, and coordinating the introduction of magnetic resonance imaging in Malawi. The children hospitalized on the Paediatric Research Ward in Blantyre are probably the most exhaustively characterized cerebral malaria patients in the world.
Since 2010, Dr. Taylor has also served as the Program Director for the Malawi ICEMR (International Centers of Excellence in Malaria Research). With ICEMR support, the team has established the capacity for eco-entomological field work in Malawi, executed a series of cross-sectional surveys, carried out inpatient and outpatient facility-based surveillance, and are currently conducting 4 longitudinal cohort studies, one case-control study and a qualitative inquiry into barriers thwarting malaria control.
Disclosure: Novartis Institute of Tropical Diseases (Individual(s) Involved: Self): Board Member
Thursday, October 22, 2020
5:15pm – 6:30pm EDT
